Innovent Biologics, Inc.
Innovent Biologics, Inc. (IVBXF) Stock Competitors & Peer Comparison
See (IVBXF) competitors and their performances in Stock Market.
Peer Comparison Table: Biotechnology Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IVBXF | $10.35 | -4.17% | 18B | 147.86 | $0.07 | N/A |
| NONOF | $44.72 | -3.78% | 199.7B | 10.43 | $4.31 | +3.97% |
| CSLLY | $17.41 | -0.80% | 67.5B | 11.32 | $1.54 | +4.16% |
| UCBJF | $289.12 | -0.02% | 55B | 30.59 | $9.45 | +0.59% |
| UCBJY | $137.05 | -1.68% | 52.2B | 29.04 | $4.72 | +0.62% |
| ARGNF | $803.19 | +0.00% | 49.7B | 35.71 | $22.49 | N/A |
| CMXHF | $70.50 | -0.70% | 33.8B | 11.43 | $6.17 | +4.14% |
| WXIBF | $4.30 | +0.00% | 17.8B | 25.29 | $0.17 | N/A |
| WXXWY | $8.50 | +3.28% | 17.6B | 25.00 | $0.34 | N/A |
| GNMSF | $265.27 | -1.11% | 16.3B | 20.19 | $13.14 | N/A |
Stock Comparison
IVBXF vs NONOF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, NONOF has a market cap of 199.7B. Regarding current trading prices, IVBXF is priced at $10.35, while NONOF trades at $44.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas NONOF's P/E ratio is 10.43. In terms of profitability, IVBXF's ROE is +0.05%, compared to NONOF's ROE of +0.66%. Regarding short-term risk, IVBXF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check NONOF's competition here
IVBXF vs CSLLY Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, CSLLY has a market cap of 67.5B. Regarding current trading prices, IVBXF is priced at $10.35, while CSLLY trades at $17.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas CSLLY's P/E ratio is 11.32. In terms of profitability, IVBXF's ROE is +0.05%, compared to CSLLY's ROE of +0.08%. Regarding short-term risk, IVBXF is less volatile compared to CSLLY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check CSLLY's competition here
IVBXF vs UCBJF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, UCBJF has a market cap of 55B. Regarding current trading prices, IVBXF is priced at $10.35, while UCBJF trades at $289.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas UCBJF's P/E ratio is 30.59. In terms of profitability, IVBXF's ROE is +0.05%, compared to UCBJF's ROE of +0.15%. Regarding short-term risk, IVBXF is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check UCBJF's competition here
IVBXF vs UCBJY Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, UCBJY has a market cap of 52.2B. Regarding current trading prices, IVBXF is priced at $10.35, while UCBJY trades at $137.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas UCBJY's P/E ratio is 29.04. In terms of profitability, IVBXF's ROE is +0.05%, compared to UCBJY's ROE of +0.15%. Regarding short-term risk, IVBXF is less volatile compared to UCBJY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check UCBJY's competition here
IVBXF vs ARGNF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, ARGNF has a market cap of 49.7B. Regarding current trading prices, IVBXF is priced at $10.35, while ARGNF trades at $803.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas ARGNF's P/E ratio is 35.71. In terms of profitability, IVBXF's ROE is +0.05%, compared to ARGNF's ROE of +0.34%. Regarding short-term risk, IVBXF is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check ARGNF's competition here
IVBXF vs CMXHF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, CMXHF has a market cap of 33.8B. Regarding current trading prices, IVBXF is priced at $10.35, while CMXHF trades at $70.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas CMXHF's P/E ratio is 11.43. In terms of profitability, IVBXF's ROE is +0.05%, compared to CMXHF's ROE of +0.08%. Regarding short-term risk, IVBXF is less volatile compared to CMXHF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check CMXHF's competition here
IVBXF vs WXIBF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, WXIBF has a market cap of 17.8B. Regarding current trading prices, IVBXF is priced at $10.35, while WXIBF trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas WXIBF's P/E ratio is 25.29. In terms of profitability, IVBXF's ROE is +0.05%, compared to WXIBF's ROE of +0.11%. Regarding short-term risk, IVBXF is less volatile compared to WXIBF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check WXIBF's competition here
IVBXF vs WXXWY Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, WXXWY has a market cap of 17.6B. Regarding current trading prices, IVBXF is priced at $10.35, while WXXWY trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas WXXWY's P/E ratio is 25.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to WXXWY's ROE of +0.11%. Regarding short-term risk, IVBXF is less volatile compared to WXXWY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check WXXWY's competition here
IVBXF vs GNMSF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, GNMSF has a market cap of 16.3B. Regarding current trading prices, IVBXF is priced at $10.35, while GNMSF trades at $265.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas GNMSF's P/E ratio is 20.19. In terms of profitability, IVBXF's ROE is +0.05%, compared to GNMSF's ROE of +0.21%. Regarding short-term risk, IVBXF is less volatile compared to GNMSF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check GNMSF's competition here
IVBXF vs SBHMY Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, SBHMY has a market cap of 12.7B. Regarding current trading prices, IVBXF is priced at $10.35, while SBHMY trades at $14.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas SBHMY's P/E ratio is 37.59. In terms of profitability, IVBXF's ROE is +0.05%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, IVBXF is less volatile compared to SBHMY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check SBHMY's competition here
IVBXF vs SBMFF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, SBMFF has a market cap of 12.4B. Regarding current trading prices, IVBXF is priced at $10.35, while SBMFF trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas SBMFF's P/E ratio is 23.07. In terms of profitability, IVBXF's ROE is +0.05%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, IVBXF is more volatile compared to SBMFF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check SBMFF's competition here
IVBXF vs BRRGF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, BRRGF has a market cap of 9.5B. Regarding current trading prices, IVBXF is priced at $10.35, while BRRGF trades at $97.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas BRRGF's P/E ratio is -0.48. In terms of profitability, IVBXF's ROE is +0.05%, compared to BRRGF's ROE of -0.97%. Regarding short-term risk, IVBXF is less volatile compared to BRRGF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check BRRGF's competition here
IVBXF vs AAVXF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, AAVXF has a market cap of 9.2B. Regarding current trading prices, IVBXF is priced at $10.35, while AAVXF trades at $115.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas AAVXF's P/E ratio is -22.11. In terms of profitability, IVBXF's ROE is +0.05%, compared to AAVXF's ROE of -1.65%. Regarding short-term risk, IVBXF is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check AAVXF's competition here
IVBXF vs ODTC Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, ODTC has a market cap of 8B. Regarding current trading prices, IVBXF is priced at $10.35, while ODTC trades at $22,005.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas ODTC's P/E ratio is 1.07. In terms of profitability, IVBXF's ROE is +0.05%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, IVBXF is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check ODTC's competition here
IVBXF vs AKBLF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, AKBLF has a market cap of 7.2B. Regarding current trading prices, IVBXF is priced at $10.35, while AKBLF trades at $35.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas AKBLF's P/E ratio is 39.07. In terms of profitability, IVBXF's ROE is +0.05%, compared to AKBLF's ROE of +0.20%. Regarding short-term risk, IVBXF is less volatile compared to AKBLF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check AKBLF's competition here
IVBXF vs TRSBF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, TRSBF has a market cap of 7.1B. Regarding current trading prices, IVBXF is priced at $10.35, while TRSBF trades at $2.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas TRSBF's P/E ratio is 5.70. In terms of profitability, IVBXF's ROE is +0.05%, compared to TRSBF's ROE of +0.38%. Regarding short-term risk, IVBXF is less volatile compared to TRSBF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check TRSBF's competition here
IVBXF vs REGMF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, REGMF has a market cap of 6.8B. Regarding current trading prices, IVBXF is priced at $10.35, while REGMF trades at $12.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas REGMF's P/E ratio is 63.42. In terms of profitability, IVBXF's ROE is +0.05%, compared to REGMF's ROE of +0.42%. Regarding short-term risk, IVBXF is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check REGMF's competition here
IVBXF vs ABCZF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, IVBXF is priced at $10.35, while ABCZF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to ABCZF's ROE of +0.29%. Regarding short-term risk, IVBXF is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check ABCZF's competition here
IVBXF vs SHJBF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, SHJBF has a market cap of 4.8B. Regarding current trading prices, IVBXF is priced at $10.35, while SHJBF trades at $3.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas SHJBF's P/E ratio is -27.92. In terms of profitability, IVBXF's ROE is +0.05%, compared to SHJBF's ROE of -0.11%. Regarding short-term risk, IVBXF is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check SHJBF's competition here
IVBXF vs GNNSF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, GNNSF has a market cap of 3.8B. Regarding current trading prices, IVBXF is priced at $10.35, while GNNSF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas GNNSF's P/E ratio is -6.90. In terms of profitability, IVBXF's ROE is +0.05%, compared to GNNSF's ROE of -0.13%. Regarding short-term risk, IVBXF is less volatile compared to GNNSF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check GNNSF's competition here
IVBXF vs ZLDPF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, ZLDPF has a market cap of 3.5B. Regarding current trading prices, IVBXF is priced at $10.35, while ZLDPF trades at $48.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas ZLDPF's P/E ratio is 3.47. In terms of profitability, IVBXF's ROE is +0.05%, compared to ZLDPF's ROE of +0.43%. Regarding short-term risk, IVBXF is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check ZLDPF's competition here
IVBXF vs TLPPF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, TLPPF has a market cap of 3.3B. Regarding current trading prices, IVBXF is priced at $10.35, while TLPPF trades at $9.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas TLPPF's P/E ratio is -487.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to TLPPF's ROE of -0.02%. Regarding short-term risk, IVBXF is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check TLPPF's competition here
IVBXF vs BRCTF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, BRCTF has a market cap of 2.9B. Regarding current trading prices, IVBXF is priced at $10.35, while BRCTF trades at $33.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas BRCTF's P/E ratio is 26.63. In terms of profitability, IVBXF's ROE is +0.05%, compared to BRCTF's ROE of +0.52%. Regarding short-term risk, IVBXF is less volatile compared to BRCTF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check BRCTF's competition here
IVBXF vs MPSYF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, IVBXF is priced at $10.35, while MPSYF trades at $73.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, IVBXF's ROE is +0.05%, compared to MPSYF's ROE of -1.84%. Regarding short-term risk, IVBXF is less volatile compared to MPSYF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check MPSYF's competition here
IVBXF vs BVNKF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, BVNKF has a market cap of 2.3B. Regarding current trading prices, IVBXF is priced at $10.35, while BVNKF trades at $30.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas BVNKF's P/E ratio is 12.84. In terms of profitability, IVBXF's ROE is +0.05%, compared to BVNKF's ROE of +0.09%. Regarding short-term risk, IVBXF is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check BVNKF's competition here
IVBXF vs INCPF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, INCPF has a market cap of 2.3B. Regarding current trading prices, IVBXF is priced at $10.35, while INCPF trades at $1.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas INCPF's P/E ratio is 25.83. In terms of profitability, IVBXF's ROE is +0.05%, compared to INCPF's ROE of +0.10%. Regarding short-term risk, IVBXF is less volatile compared to INCPF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check INCPF's competition here
IVBXF vs BVNRY Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, BVNRY has a market cap of 2.3B. Regarding current trading prices, IVBXF is priced at $10.35, while BVNRY trades at $9.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas BVNRY's P/E ratio is 12.27. In terms of profitability, IVBXF's ROE is +0.05%, compared to BVNRY's ROE of +0.11%. Regarding short-term risk, IVBXF is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check BVNRY's competition here
IVBXF vs ASCLF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, ASCLF has a market cap of 2.3B. Regarding current trading prices, IVBXF is priced at $10.35, while ASCLF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas ASCLF's P/E ratio is -42.84. In terms of profitability, IVBXF's ROE is +0.05%, compared to ASCLF's ROE of -0.19%. Regarding short-term risk, IVBXF is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check ASCLF's competition here
IVBXF vs MEOBF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, MEOBF has a market cap of 2.2B. Regarding current trading prices, IVBXF is priced at $10.35, while MEOBF trades at $1.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas MEOBF's P/E ratio is -24.29. In terms of profitability, IVBXF's ROE is +0.05%, compared to MEOBF's ROE of -0.14%. Regarding short-term risk, IVBXF is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check MEOBF's competition here
IVBXF vs GENSF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, GENSF has a market cap of 2.1B. Regarding current trading prices, IVBXF is priced at $10.35, while GENSF trades at $31.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas GENSF's P/E ratio is 32.03. In terms of profitability, IVBXF's ROE is +0.05%, compared to GENSF's ROE of +0.10%. Regarding short-term risk, IVBXF is less volatile compared to GENSF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check GENSF's competition here
IVBXF vs ASPHF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, ASPHF has a market cap of 1.9B. Regarding current trading prices, IVBXF is priced at $10.35, while ASPHF trades at $5.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas ASPHF's P/E ratio is -9.53. In terms of profitability, IVBXF's ROE is +0.05%, compared to ASPHF's ROE of -0.73%. Regarding short-term risk, IVBXF is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check ASPHF's competition here
IVBXF vs GLPGF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, GLPGF has a market cap of 1.9B. Regarding current trading prices, IVBXF is priced at $10.35, while GLPGF trades at $28.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas GLPGF's P/E ratio is -3.50. In terms of profitability, IVBXF's ROE is +0.05%, compared to GLPGF's ROE of +0.16%. Regarding short-term risk, IVBXF is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check GLPGF's competition here
IVBXF vs PHMMF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, PHMMF has a market cap of 1.8B. Regarding current trading prices, IVBXF is priced at $10.35, while PHMMF trades at $106.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas PHMMF's P/E ratio is 46.29. In terms of profitability, IVBXF's ROE is +0.05%, compared to PHMMF's ROE of +0.36%. Regarding short-term risk, IVBXF is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check PHMMF's competition here
IVBXF vs CSPHF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, CSPHF has a market cap of 1.6B. Regarding current trading prices, IVBXF is priced at $10.35, while CSPHF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas CSPHF's P/E ratio is -20.20. In terms of profitability, IVBXF's ROE is +0.05%, compared to CSPHF's ROE of -0.64%. Regarding short-term risk, IVBXF is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check CSPHF's competition here
IVBXF vs BIESF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, IVBXF is priced at $10.35, while BIESF trades at $32.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas BIESF's P/E ratio is -44.44. In terms of profitability, IVBXF's ROE is +0.05%, compared to BIESF's ROE of -0.05%. Regarding short-term risk, IVBXF is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check BIESF's competition here
IVBXF vs ONTTF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, ONTTF has a market cap of 1.6B. Regarding current trading prices, IVBXF is priced at $10.35, while ONTTF trades at $1.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas ONTTF's P/E ratio is -7.76. In terms of profitability, IVBXF's ROE is +0.05%, compared to ONTTF's ROE of -0.29%. Regarding short-term risk, IVBXF is less volatile compared to ONTTF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check ONTTF's competition here
IVBXF vs IDRSF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, IDRSF has a market cap of 1.4B. Regarding current trading prices, IVBXF is priced at $10.35, while IDRSF trades at $5.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas IDRSF's P/E ratio is -4.36. In terms of profitability, IVBXF's ROE is +0.05%, compared to IDRSF's ROE of +0.19%. Regarding short-term risk, IVBXF is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check IDRSF's competition here
IVBXF vs HBMHF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, HBMHF has a market cap of 1.3B. Regarding current trading prices, IVBXF is priced at $10.35, while HBMHF trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas HBMHF's P/E ratio is 13.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to HBMHF's ROE of +0.28%. Regarding short-term risk, IVBXF is less volatile compared to HBMHF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check HBMHF's competition here
IVBXF vs SNBIF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, SNBIF has a market cap of 1.3B. Regarding current trading prices, IVBXF is priced at $10.35, while SNBIF trades at $16.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas SNBIF's P/E ratio is -49.85. In terms of profitability, IVBXF's ROE is +0.05%, compared to SNBIF's ROE of -0.89%. Regarding short-term risk, IVBXF is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check SNBIF's competition here
IVBXF vs MDCLF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, MDCLF has a market cap of 1.2B. Regarding current trading prices, IVBXF is priced at $10.35, while MDCLF trades at $34.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas MDCLF's P/E ratio is -47.76. In terms of profitability, IVBXF's ROE is +0.05%, compared to MDCLF's ROE of +0.84%. Regarding short-term risk, IVBXF is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check MDCLF's competition here
IVBXF vs NURPF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, NURPF has a market cap of 1.1B. Regarding current trading prices, IVBXF is priced at $10.35, while NURPF trades at $8.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas NURPF's P/E ratio is 52.21. In terms of profitability, IVBXF's ROE is +0.05%, compared to NURPF's ROE of +0.09%. Regarding short-term risk, IVBXF is less volatile compared to NURPF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check NURPF's competition here
IVBXF vs CSBTF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, CSBTF has a market cap of 975.4M. Regarding current trading prices, IVBXF is priced at $10.35, while CSBTF trades at $24.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas CSBTF's P/E ratio is 309.38. In terms of profitability, IVBXF's ROE is +0.05%, compared to CSBTF's ROE of +0.02%. Regarding short-term risk, IVBXF is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check CSBTF's competition here
IVBXF vs BTTAY Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, BTTAY has a market cap of 943M. Regarding current trading prices, IVBXF is priced at $10.35, while BTTAY trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, IVBXF's ROE is +0.05%, compared to BTTAY's ROE of -0.05%. Regarding short-term risk, IVBXF is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check BTTAY's competition here
IVBXF vs PPTDF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, PPTDF has a market cap of 902M. Regarding current trading prices, IVBXF is priced at $10.35, while PPTDF trades at $7.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas PPTDF's P/E ratio is -39.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to PPTDF's ROE of -0.05%. Regarding short-term risk, IVBXF is more volatile compared to PPTDF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check PPTDF's competition here
IVBXF vs TKBIF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, TKBIF has a market cap of 879M. Regarding current trading prices, IVBXF is priced at $10.35, while TKBIF trades at $7.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas TKBIF's P/E ratio is -14.31. In terms of profitability, IVBXF's ROE is +0.05%, compared to TKBIF's ROE of N/A. Regarding short-term risk, IVBXF is less volatile compared to TKBIF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check TKBIF's competition here
IVBXF vs PHGUF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, PHGUF has a market cap of 875.8M. Regarding current trading prices, IVBXF is priced at $10.35, while PHGUF trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas PHGUF's P/E ratio is 62.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to PHGUF's ROE of +0.05%. Regarding short-term risk, IVBXF is less volatile compared to PHGUF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check PHGUF's competition here
IVBXF vs BPMUF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, BPMUF has a market cap of 853.8M. Regarding current trading prices, IVBXF is priced at $10.35, while BPMUF trades at $69.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas BPMUF's P/E ratio is 9.69. In terms of profitability, IVBXF's ROE is +0.05%, compared to BPMUF's ROE of +0.35%. Regarding short-term risk, IVBXF is more volatile compared to BPMUF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check BPMUF's competition here
IVBXF vs IVEVF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, IVEVF has a market cap of 741.2M. Regarding current trading prices, IVBXF is priced at $10.35, while IVEVF trades at $5.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas IVEVF's P/E ratio is -2.38. In terms of profitability, IVBXF's ROE is +0.05%, compared to IVEVF's ROE of +18.92%. Regarding short-term risk, IVBXF is less volatile compared to IVEVF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check IVEVF's competition here
IVBXF vs SOLTF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, SOLTF has a market cap of 613.7M. Regarding current trading prices, IVBXF is priced at $10.35, while SOLTF trades at $6.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas SOLTF's P/E ratio is -7.60. In terms of profitability, IVBXF's ROE is +0.05%, compared to SOLTF's ROE of -0.16%. Regarding short-term risk, IVBXF is less volatile compared to SOLTF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check SOLTF's competition here
IVBXF vs CKDXF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, CKDXF has a market cap of 601.9M. Regarding current trading prices, IVBXF is priced at $10.35, while CKDXF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, IVBXF's ROE is +0.05%, compared to CKDXF's ROE of +0.84%. Regarding short-term risk, IVBXF is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check CKDXF's competition here
IVBXF vs AVCTF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, AVCTF has a market cap of 538M. Regarding current trading prices, IVBXF is priced at $10.35, while AVCTF trades at $1.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas AVCTF's P/E ratio is -8.20. In terms of profitability, IVBXF's ROE is +0.05%, compared to AVCTF's ROE of -3.76%. Regarding short-term risk, IVBXF is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check AVCTF's competition here
IVBXF vs INRLF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, INRLF has a market cap of 489.3M. Regarding current trading prices, IVBXF is priced at $10.35, while INRLF trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas INRLF's P/E ratio is -2.74. In terms of profitability, IVBXF's ROE is +0.05%, compared to INRLF's ROE of -1.06%. Regarding short-term risk, IVBXF is less volatile compared to INRLF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check INRLF's competition here
IVBXF vs CYDY Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, CYDY has a market cap of 476.7M. Regarding current trading prices, IVBXF is priced at $10.35, while CYDY trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas CYDY's P/E ratio is -8.72. In terms of profitability, IVBXF's ROE is +0.05%, compared to CYDY's ROE of +0.37%. Regarding short-term risk, IVBXF is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check CYDY's competition here
IVBXF vs GNFTF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, GNFTF has a market cap of 474.3M. Regarding current trading prices, IVBXF is priced at $10.35, while GNFTF trades at $9.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas GNFTF's P/E ratio is -4.69. In terms of profitability, IVBXF's ROE is +0.05%, compared to GNFTF's ROE of -5.96%. Regarding short-term risk, IVBXF is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check GNFTF's competition here
IVBXF vs RAONF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, RAONF has a market cap of 451.7M. Regarding current trading prices, IVBXF is priced at $10.35, while RAONF trades at $2.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas RAONF's P/E ratio is -43.33. In terms of profitability, IVBXF's ROE is +0.05%, compared to RAONF's ROE of -0.26%. Regarding short-term risk, IVBXF is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check RAONF's competition here
IVBXF vs GNFTY Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, GNFTY has a market cap of 447.8M. Regarding current trading prices, IVBXF is priced at $10.35, while GNFTY trades at $8.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas GNFTY's P/E ratio is -9.94. In terms of profitability, IVBXF's ROE is +0.05%, compared to GNFTY's ROE of -0.69%. Regarding short-term risk, IVBXF is less volatile compared to GNFTY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check GNFTY's competition here
IVBXF vs TBGNF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, IVBXF is priced at $10.35, while TBGNF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, IVBXF's ROE is +0.05%, compared to TBGNF's ROE of -0.01%. Regarding short-term risk, IVBXF is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check TBGNF's competition here
IVBXF vs VBIZF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, VBIZF has a market cap of 427.9M. Regarding current trading prices, IVBXF is priced at $10.35, while VBIZF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas VBIZF's P/E ratio is 20.27. In terms of profitability, IVBXF's ROE is +0.05%, compared to VBIZF's ROE of +0.06%. Regarding short-term risk, IVBXF is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check VBIZF's competition here
IVBXF vs NWPHF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, NWPHF has a market cap of 416.1M. Regarding current trading prices, IVBXF is priced at $10.35, while NWPHF trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas NWPHF's P/E ratio is -25.97. In terms of profitability, IVBXF's ROE is +0.05%, compared to NWPHF's ROE of +16.69%. Regarding short-term risk, IVBXF is less volatile compared to NWPHF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check NWPHF's competition here
IVBXF vs PTCHF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, PTCHF has a market cap of 411.4M. Regarding current trading prices, IVBXF is priced at $10.35, while PTCHF trades at $1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas PTCHF's P/E ratio is -3.67. In terms of profitability, IVBXF's ROE is +0.05%, compared to PTCHF's ROE of -0.32%. Regarding short-term risk, IVBXF is less volatile compared to PTCHF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check PTCHF's competition here
IVBXF vs NWBO Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, NWBO has a market cap of 404.9M. Regarding current trading prices, IVBXF is priced at $10.35, while NWBO trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas NWBO's P/E ratio is -6.30. In terms of profitability, IVBXF's ROE is +0.05%, compared to NWBO's ROE of +0.71%. Regarding short-term risk, IVBXF is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check NWBO's competition here
IVBXF vs CLVLY Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, CLVLY has a market cap of 344.8M. Regarding current trading prices, IVBXF is priced at $10.35, while CLVLY trades at $6.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas CLVLY's P/E ratio is 14.55. In terms of profitability, IVBXF's ROE is +0.05%, compared to CLVLY's ROE of +0.13%. Regarding short-term risk, IVBXF is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check CLVLY's competition here
IVBXF vs CLVLF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, CLVLF has a market cap of 343.8M. Regarding current trading prices, IVBXF is priced at $10.35, while CLVLF trades at $6.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas CLVLF's P/E ratio is 14.51. In terms of profitability, IVBXF's ROE is +0.05%, compared to CLVLF's ROE of +0.13%. Regarding short-term risk, IVBXF is less volatile compared to CLVLF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check CLVLF's competition here
IVBXF vs SPHDF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, SPHDF has a market cap of 337.7M. Regarding current trading prices, IVBXF is priced at $10.35, while SPHDF trades at $23.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas SPHDF's P/E ratio is -4.80. In terms of profitability, IVBXF's ROE is +0.05%, compared to SPHDF's ROE of +6.85%. Regarding short-term risk, IVBXF is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check SPHDF's competition here
IVBXF vs NGENF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, NGENF has a market cap of 312.9M. Regarding current trading prices, IVBXF is priced at $10.35, while NGENF trades at $3.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas NGENF's P/E ratio is -15.19. In terms of profitability, IVBXF's ROE is +0.05%, compared to NGENF's ROE of -974.60%. Regarding short-term risk, IVBXF is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check NGENF's competition here
IVBXF vs FGHQF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, FGHQF has a market cap of 304.2M. Regarding current trading prices, IVBXF is priced at $10.35, while FGHQF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas FGHQF's P/E ratio is 15.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to FGHQF's ROE of +0.02%. Regarding short-term risk, IVBXF is more volatile compared to FGHQF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check FGHQF's competition here
IVBXF vs PBBIF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, IVBXF is priced at $10.35, while PBBIF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, IVBXF's ROE is +0.05%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, IVBXF is more volatile compared to PBBIF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check PBBIF's competition here
IVBXF vs ORPOF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, ORPOF has a market cap of 260.3M. Regarding current trading prices, IVBXF is priced at $10.35, while ORPOF trades at $11.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas ORPOF's P/E ratio is -11.86. In terms of profitability, IVBXF's ROE is +0.05%, compared to ORPOF's ROE of N/A. Regarding short-term risk, IVBXF is more volatile compared to ORPOF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check ORPOF's competition here
IVBXF vs ORYZF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, ORYZF has a market cap of 258.9M. Regarding current trading prices, IVBXF is priced at $10.35, while ORYZF trades at $3.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas ORYZF's P/E ratio is -83.50. In terms of profitability, IVBXF's ROE is +0.05%, compared to ORYZF's ROE of -0.03%. Regarding short-term risk, IVBXF is less volatile compared to ORYZF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check ORYZF's competition here
IVBXF vs HNSBF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, HNSBF has a market cap of 245.8M. Regarding current trading prices, IVBXF is priced at $10.35, while HNSBF trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas HNSBF's P/E ratio is -3.41. In terms of profitability, IVBXF's ROE is +0.05%, compared to HNSBF's ROE of +2.02%. Regarding short-term risk, IVBXF is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check HNSBF's competition here
IVBXF vs HLOSF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, HLOSF has a market cap of 236.9M. Regarding current trading prices, IVBXF is priced at $10.35, while HLOSF trades at $2.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas HLOSF's P/E ratio is -12.94. In terms of profitability, IVBXF's ROE is +0.05%, compared to HLOSF's ROE of -0.75%. Regarding short-term risk, IVBXF is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check HLOSF's competition here
IVBXF vs SCNLF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, SCNLF has a market cap of 236.6M. Regarding current trading prices, IVBXF is priced at $10.35, while SCNLF trades at $0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas SCNLF's P/E ratio is -22.80. In terms of profitability, IVBXF's ROE is +0.05%, compared to SCNLF's ROE of +0.90%. Regarding short-term risk, IVBXF is less volatile compared to SCNLF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check SCNLF's competition here
IVBXF vs CMVLF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, CMVLF has a market cap of 222.8M. Regarding current trading prices, IVBXF is priced at $10.35, while CMVLF trades at $3.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas CMVLF's P/E ratio is -4.60. In terms of profitability, IVBXF's ROE is +0.05%, compared to CMVLF's ROE of -0.81%. Regarding short-term risk, IVBXF is more volatile compared to CMVLF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check CMVLF's competition here
IVBXF vs BOVNF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, BOVNF has a market cap of 216.4M. Regarding current trading prices, IVBXF is priced at $10.35, while BOVNF trades at $3.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas BOVNF's P/E ratio is -7.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to BOVNF's ROE of -0.54%. Regarding short-term risk, IVBXF is less volatile compared to BOVNF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check BOVNF's competition here
IVBXF vs IPHYF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, IPHYF has a market cap of 211.1M. Regarding current trading prices, IVBXF is priced at $10.35, while IPHYF trades at $2.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas IPHYF's P/E ratio is -3.46. In terms of profitability, IVBXF's ROE is +0.05%, compared to IPHYF's ROE of +5.94%. Regarding short-term risk, IVBXF is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check IPHYF's competition here
IVBXF vs FPHAF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, IVBXF is priced at $10.35, while FPHAF trades at $3.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, IVBXF's ROE is +0.05%, compared to FPHAF's ROE of +0.00%. Regarding short-term risk, IVBXF is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check FPHAF's competition here
IVBXF vs SLNCF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, SLNCF has a market cap of 205.8M. Regarding current trading prices, IVBXF is priced at $10.35, while SLNCF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas SLNCF's P/E ratio is -2.69. In terms of profitability, IVBXF's ROE is +0.05%, compared to SLNCF's ROE of -1.15%. Regarding short-term risk, IVBXF is less volatile compared to SLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check SLNCF's competition here
IVBXF vs PHCUF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, PHCUF has a market cap of 196.6M. Regarding current trading prices, IVBXF is priced at $10.35, while PHCUF trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas PHCUF's P/E ratio is 21.74. In terms of profitability, IVBXF's ROE is +0.05%, compared to PHCUF's ROE of +0.17%. Regarding short-term risk, IVBXF is less volatile compared to PHCUF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check PHCUF's competition here
IVBXF vs SPHRY Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, SPHRY has a market cap of 192.8M. Regarding current trading prices, IVBXF is priced at $10.35, while SPHRY trades at $4.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas SPHRY's P/E ratio is -76.33. In terms of profitability, IVBXF's ROE is +0.05%, compared to SPHRY's ROE of -0.05%. Regarding short-term risk, IVBXF is less volatile compared to SPHRY. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check SPHRY's competition here
IVBXF vs SPHRF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, SPHRF has a market cap of 183.1M. Regarding current trading prices, IVBXF is priced at $10.35, while SPHRF trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas SPHRF's P/E ratio is -43.50. In terms of profitability, IVBXF's ROE is +0.05%, compared to SPHRF's ROE of -0.16%. Regarding short-term risk, IVBXF is more volatile compared to SPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check SPHRF's competition here
IVBXF vs ADOCY Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, ADOCY has a market cap of 170.4M. Regarding current trading prices, IVBXF is priced at $10.35, while ADOCY trades at $11.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas ADOCY's P/E ratio is -3.36. In terms of profitability, IVBXF's ROE is +0.05%, compared to ADOCY's ROE of +8.60%. Regarding short-term risk, IVBXF is more volatile compared to ADOCY. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check ADOCY's competition here
IVBXF vs KNTPF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, KNTPF has a market cap of 169.3M. Regarding current trading prices, IVBXF is priced at $10.35, while KNTPF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas KNTPF's P/E ratio is -6.02. In terms of profitability, IVBXF's ROE is +0.05%, compared to KNTPF's ROE of -0.63%. Regarding short-term risk, IVBXF is more volatile compared to KNTPF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check KNTPF's competition here
IVBXF vs BBIXF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, BBIXF has a market cap of 151.8M. Regarding current trading prices, IVBXF is priced at $10.35, while BBIXF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas BBIXF's P/E ratio is -13.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to BBIXF's ROE of -15.41%. Regarding short-term risk, IVBXF is less volatile compared to BBIXF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check BBIXF's competition here
IVBXF vs AMGXF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, AMGXF has a market cap of 142.5M. Regarding current trading prices, IVBXF is priced at $10.35, while AMGXF trades at $0.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, IVBXF's ROE is +0.05%, compared to AMGXF's ROE of -0.71%. Regarding short-term risk, IVBXF is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check AMGXF's competition here
IVBXF vs BRIBF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, BRIBF has a market cap of 135.7M. Regarding current trading prices, IVBXF is priced at $10.35, while BRIBF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas BRIBF's P/E ratio is -3.76. In terms of profitability, IVBXF's ROE is +0.05%, compared to BRIBF's ROE of -0.09%. Regarding short-term risk, IVBXF is less volatile compared to BRIBF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check BRIBF's competition here
IVBXF vs HBPCF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, HBPCF has a market cap of 132.1M. Regarding current trading prices, IVBXF is priced at $10.35, while HBPCF trades at $1.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas HBPCF's P/E ratio is -43.25. In terms of profitability, IVBXF's ROE is +0.05%, compared to HBPCF's ROE of -0.37%. Regarding short-term risk, IVBXF is more volatile compared to HBPCF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check HBPCF's competition here
IVBXF vs AAPGV Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, IVBXF is priced at $10.35, while AAPGV trades at $17.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas AAPGV's P/E ratio is N/A. In terms of profitability, IVBXF's ROE is +0.05%, compared to AAPGV's ROE of -2.50%. Regarding short-term risk, IVBXF is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check AAPGV's competition here
IVBXF vs TRGNF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, TRGNF has a market cap of 122.6M. Regarding current trading prices, IVBXF is priced at $10.35, while TRGNF trades at $0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas TRGNF's P/E ratio is -2.83. In terms of profitability, IVBXF's ROE is +0.05%, compared to TRGNF's ROE of -0.64%. Regarding short-term risk, IVBXF is more volatile compared to TRGNF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check TRGNF's competition here
IVBXF vs PSTTF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, IVBXF is priced at $10.35, while PSTTF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, IVBXF's ROE is +0.05%, compared to PSTTF's ROE of N/A. Regarding short-term risk, IVBXF is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check PSTTF's competition here
IVBXF vs JWCTF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, JWCTF has a market cap of 116.7M. Regarding current trading prices, IVBXF is priced at $10.35, while JWCTF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas JWCTF's P/E ratio is -1.40. In terms of profitability, IVBXF's ROE is +0.05%, compared to JWCTF's ROE of -0.75%. Regarding short-term risk, IVBXF is less volatile compared to JWCTF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check JWCTF's competition here
IVBXF vs EPRXF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, IVBXF is priced at $10.35, while EPRXF trades at $3.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, IVBXF's ROE is +0.05%, compared to EPRXF's ROE of -4.83%. Regarding short-term risk, IVBXF is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check EPRXF's competition here
IVBXF vs ADOIF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, IVBXF is priced at $10.35, while ADOIF trades at $8.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, IVBXF's ROE is +0.05%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, IVBXF is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check ADOIF's competition here
IVBXF vs MSCLF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, MSCLF has a market cap of 96.6M. Regarding current trading prices, IVBXF is priced at $10.35, while MSCLF trades at $6.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas MSCLF's P/E ratio is 2.43. In terms of profitability, IVBXF's ROE is +0.05%, compared to MSCLF's ROE of -0.70%. Regarding short-term risk, IVBXF is less volatile compared to MSCLF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check MSCLF's competition here
IVBXF vs MLLCF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, MLLCF has a market cap of 95.4M. Regarding current trading prices, IVBXF is priced at $10.35, while MLLCF trades at $2.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas MLLCF's P/E ratio is -1.29. In terms of profitability, IVBXF's ROE is +0.05%, compared to MLLCF's ROE of -0.66%. Regarding short-term risk, IVBXF is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check MLLCF's competition here
IVBXF vs MCURF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, IVBXF is priced at $10.35, while MCURF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas MCURF's P/E ratio is -16.90. In terms of profitability, IVBXF's ROE is +0.05%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, IVBXF is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check MCURF's competition here
IVBXF vs RECEF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, RECEF has a market cap of 80.4M. Regarding current trading prices, IVBXF is priced at $10.35, while RECEF trades at $0.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas RECEF's P/E ratio is -3.67. In terms of profitability, IVBXF's ROE is +0.05%, compared to RECEF's ROE of +2.79%. Regarding short-term risk, IVBXF is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check RECEF's competition here
IVBXF vs ETXPF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, ETXPF has a market cap of 76M. Regarding current trading prices, IVBXF is priced at $10.35, while ETXPF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas ETXPF's P/E ratio is -6.50. In terms of profitability, IVBXF's ROE is +0.05%, compared to ETXPF's ROE of -0.51%. Regarding short-term risk, IVBXF is more volatile compared to ETXPF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check ETXPF's competition here
IVBXF vs PRRUF Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, PRRUF has a market cap of 73.7M. Regarding current trading prices, IVBXF is priced at $10.35, while PRRUF trades at $0.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas PRRUF's P/E ratio is -1.25. In terms of profitability, IVBXF's ROE is +0.05%, compared to PRRUF's ROE of -0.53%. Regarding short-term risk, IVBXF is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for IVBXF.Check PRRUF's competition here
IVBXF vs BSEM Comparison May 2026
IVBXF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IVBXF stands at 18B. In comparison, BSEM has a market cap of 72.4M. Regarding current trading prices, IVBXF is priced at $10.35, while BSEM trades at $4.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IVBXF currently has a P/E ratio of 147.86, whereas BSEM's P/E ratio is 4.89. In terms of profitability, IVBXF's ROE is +0.05%, compared to BSEM's ROE of -0.14%. Regarding short-term risk, IVBXF is less volatile compared to BSEM. This indicates potentially lower risk in terms of short-term price fluctuations for IVBXF.Check BSEM's competition here